Is meropenem an appropriate treatment for leptospirosis, and what dosing and duration should be used?

Meropenem is NOT a standard or recommended treatment for leptospirosis

Based on available evidence, meropenem should not be used for leptospirosis treatment. While one recent case report describes successful use of meropenem in a patient with severe leptospirosis who had hypersensitivity to first-line agents 1, this represents an exceptional circumstance rather than evidence-based practice. The systematic reviews and meta-analyses on leptospirosis treatment do not include meropenem among evaluated antibiotics 2, 3.

Recommended Antibiotics for Leptospirosis

The evidence supports the following antibiotics, which significantly reduce defervescence time 2:

First-Line Options (in order of efficacy for defervescence):

• Cefotaxime (most effective: MD -1.88 days)
• Azithromycin (MD -1.74 days)
• Doxycycline (MD -1.53 days)
• Ceftriaxone (MD -1.22 days)
• Penicillin (MD -1.22 days)

Dosing Recommendations:

• Doxycycline: 100 mg IV/PO twice daily for 7 days
• Ceftriaxone: 2 g IV daily for 7 days
• Penicillin G: 1.5 million units IV every 6 hours for 7 days
• Azithromycin: Consider for drug-resistant cases 2

When Meropenem Might Be Considered

Meropenem could theoretically be used only in the following exceptional scenario:

• Patient has documented hypersensitivity to ALL first-line agents (penicillins, cephalosporins, doxycycline, and azithromycin)
• Severe leptospirosis requiring immediate treatment
• No other therapeutic options available

If Meropenem Must Be Used:

Based on the single case report 1 and standard meropenem dosing for severe infections 4:

• Dose: 1 g IV every 8 hours
• Duration: 7-10 days (consistent with other leptospirosis treatments)
• Administration: Extended infusion over 30 minutes preferred
• Adjunctive therapy: Consider methylprednisolone for severe pulmonary hemorrhage syndrome 1

Critical Caveats

1. No clinical trial data: Meropenem has never been studied in randomized trials for leptospirosis 3
2. Antibiotic stewardship concern: Meropenem is a carbapenem reserved for multidrug-resistant organisms; using it for leptospirosis (which responds to narrow-spectrum agents) violates stewardship principles
3. Cost and availability: Meropenem is significantly more expensive than first-line options without proven benefit
4. Mortality benefit unclear: Even established antibiotics show uncertain mortality benefit in leptospirosis 3, so extrapolating to meropenem is speculative

Practical Algorithm

For suspected leptospirosis:

1. Start doxycycline 100 mg IV/PO twice daily OR ceftriaxone 2 g IV daily
2. If penicillin allergy: Use doxycycline (not cross-reactive)
3. If cephalosporin allergy: Use doxycycline or azithromycin
4. If severe multi-drug hypersensitivity documented: Consider azithromycin first
5. Only if ALL above contraindicated: Meropenem 1 g IV every 8 hours as last resort

The evidence does not support routine use of meropenem for leptospirosis. Stick with proven first-line agents unless truly no alternatives exist.